KISQALI 200 MG RIBOCICLIB TABLETS

Kisqali 200mg Tablet (Ribociclib)

Description:
Kisqali 200mg Tablet contains Ribociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor used in the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer.

It is usually prescribed in combination with hormone therapy (like Letrozole, Fulvestrant, or Tamoxifen). By blocking CDK4 and CDK6 enzymes, Kisqali helps stop uncontrolled cancer cell division, thereby slowing down or stopping the spread of cancer.

Key Benefits:

• Effective for postmenopausal women and men with advanced or metastatic breast cancer.

• Works in combination with hormone therapy for better results.

• Helps delay disease progression and improves survival chances.

• Provides better quality of life by controlling cancer growth.

Common Side Effects:

• Nausea and vomiting

• Diarrhea or constipation

• Fatigue and weakness

• Low blood cell counts (neutropenia, anemia)

• Headache or dizziness

• Abnormal liver function tests

• Risk of infections due to low immunity

• ECG changes (QT prolongation) in some patients

Precautions:

• Avoid during pregnancy and breastfeeding.

• Regular monitoring of liver function, ECG, and blood counts is required.

• Inform your doctor about any liver, kidney, or heart problems.

• Avoid grapefruit or grapefruit juice as it may affect medicine absorption.

• Take precautions to prevent infections, as immunity may be reduced.

FAQs:

Q1: What is Kisqali 200mg used for?
It is used with hormone therapy to treat HR+, HER2- advanced or metastatic breast cancer in women and men.

Q2: How should I take Kisqali 200mg?
It is usually taken once daily for 21 days, followed by 7 days off, completing a 28-day cycle. Always follow your doctor’s prescription.

Q3: Does Kisqali cure breast cancer?
No, it does not cure breast cancer but controls cancer growth, delays progression, and improves life expectancy.

Q4: What tests are needed while taking Kisqali?
You will need regular blood tests, liver function tests, and ECG monitoring to check for side effects.

Q5: Can men also take Kisqali?
Yes, Kisqali is also effective in men with HR+, HER2- advanced or metastatic breast cancer, along with hormone therapy.

TRUSTED Anti Cancer  MEDICINE PROVIDER – UNNATI PHARMAX

Reference:-

• EMA – Kisqali EPAR
  https://www.ema.europa.eu/en/medicines/human/EPAR/kisqali
  European Medicines Agency (EMA)efim.org

• EMA – Kisqali Product Information (SmPC PDF)
  https://www.ema.europa.eu/en/documents/product-information/kisqali-epar-product-information_en.pdf
  European Medicines Agency (EMA)

• FDA – Kisqali (ribociclib) Prescribing Information (2024 Label PDF)
  https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209092s019lbl.pdf